CN101705173A - Maca brandy and preparation method thereof - Google Patents
Maca brandy and preparation method thereof Download PDFInfo
- Publication number
- CN101705173A CN101705173A CN200910210550A CN200910210550A CN101705173A CN 101705173 A CN101705173 A CN 101705173A CN 200910210550 A CN200910210550 A CN 200910210550A CN 200910210550 A CN200910210550 A CN 200910210550A CN 101705173 A CN101705173 A CN 101705173A
- Authority
- CN
- China
- Prior art keywords
- brandy
- agate card
- former wine
- maca
- bright
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000013532 brandy Nutrition 0.000 title claims abstract description 51
- 240000000759 Lepidium meyenii Species 0.000 title abstract description 12
- 235000000421 Lepidium meyenii Nutrition 0.000 title abstract description 12
- 235000012902 lepidium meyenii Nutrition 0.000 title abstract description 12
- 238000002360 preparation method Methods 0.000 title abstract description 8
- 238000000855 fermentation Methods 0.000 claims abstract description 10
- 230000004151 fermentation Effects 0.000 claims abstract description 10
- 241000219095 Vitis Species 0.000 claims abstract description 8
- 230000001476 alcoholic effect Effects 0.000 claims abstract description 6
- 241001593968 Vitis palmata Species 0.000 claims abstract description 5
- 238000001914 filtration Methods 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims abstract description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 78
- 235000020057 cognac Nutrition 0.000 claims description 17
- 235000009392 Vitis Nutrition 0.000 claims description 6
- 238000013467 fragmentation Methods 0.000 claims description 4
- 238000006062 fragmentation reaction Methods 0.000 claims description 4
- 150000001336 alkenes Chemical class 0.000 claims description 3
- 150000001408 amides Chemical class 0.000 claims description 3
- 230000001580 bacterial effect Effects 0.000 claims description 3
- 230000002269 spontaneous effect Effects 0.000 claims description 3
- 239000000470 constituent Substances 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims 1
- 235000016709 nutrition Nutrition 0.000 abstract description 3
- 238000002791 soaking Methods 0.000 abstract description 3
- 241000219094 Vitaceae Species 0.000 abstract 2
- 235000009754 Vitis X bourquina Nutrition 0.000 abstract 2
- 235000012333 Vitis X labruscana Nutrition 0.000 abstract 2
- 235000014787 Vitis vinifera Nutrition 0.000 abstract 2
- 235000019674 grape juice Nutrition 0.000 abstract 2
- 235000021021 grapes Nutrition 0.000 abstract 2
- 238000004140 cleaning Methods 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 14
- 229940024606 amino acid Drugs 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 4
- 239000013543 active substance Substances 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 230000002124 endocrine Effects 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 230000000050 nutritive effect Effects 0.000 description 3
- 230000036299 sexual function Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 206010062767 Hypophysitis Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000003635 pituitary gland Anatomy 0.000 description 2
- 235000002378 plant sterols Nutrition 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 229960003080 taurine Drugs 0.000 description 2
- RSWGJHLUYNHPMX-UHFFFAOYSA-N 1,4a-dimethyl-7-propan-2-yl-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carboxylic acid Chemical compound C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 206010002027 Amyotrophy Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 241000219193 Brassicaceae Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 206010051482 Prostatomegaly Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000033781 Thyroid carcinoma Diseases 0.000 description 1
- 208000024770 Thyroid neoplasm Diseases 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- -1 Xie Ansuan Chemical compound 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003080 antimitotic agent Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- MDKCFLQDBWCQCV-UHFFFAOYSA-N benzyl isothiocyanate Chemical compound S=C=NCC1=CC=CC=C1 MDKCFLQDBWCQCV-UHFFFAOYSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036624 brainpower Effects 0.000 description 1
- 150000005693 branched-chain amino acids Chemical class 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical class C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 229960004232 linoleic acid Drugs 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000004243 retinal function Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 201000002510 thyroid cancer Diseases 0.000 description 1
- 208000013077 thyroid gland carcinoma Diseases 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Alcoholic Beverages (AREA)
Abstract
The invention relates to a preparation method for maca brandy and belongs to the field of wine products. The preparation method comprises the following steps of: removing stems of low-sugar degree white grapes or red grapes, crushing the grapes, separating out grape juice in a self flowing mode, and naturally fermenting the grape juice to prepare a raw grape wine, wherein the fermentation temperature is 29 to 32 DEG C; when the fermentation is completely finished, residual sugar is decreased to less than 3g/L, and the volatile acidity is less than or equal to 0.05 percent, stilling the raw grape wine into the raw brandy, wherein the alcoholic strength of the raw brandy is 39 to 45 degrees; and cleaning and slicing maca fruits, soaking 5 to 50 weight percent of fresh maca in 95 to 50 weight percent of raw brandy for over 6 months or soaking 1 to 15 weight percent of dry maca in 99 to 85 weight percent of the raw brandy for over 10 months to prepare raw maca brandy, and storing and filtering the raw maca brandy to prepare the maca brandy. The maca brandy prepared by the method fully maintains the nutritional and health-care components of the maca and is a good drink.
Description
(1) technical field
The present invention relates to a kind of preparation method of agate card cognac, belong to the wine product field.This method, be to hang down pol (110-160g/l) Fructus Vins or red grape through destemming fragmentation, fermentation, distillation, make the former wine of brandy, dry in the shade after brighter agate card being cleaned section or section, in the former wine of brandy, soak, through filtering, bottling, make the processing method of agate card cognac again.
(2) background technology
The international title maca of agate card----(formal name used at school LEPIDIUM MEYENII WALP) belongs to Cruciferae separate row Vegetable spp plant.Originate in Peru, be called Peru's genseng or North America genseng by people.Now by the success of Yunnan Province of China Lijing introduction of plant.It grows in height above sea level 3500-4500 rice plateau, the temperature difference big (day and night temperature 30-50 ℃), illumination fully, ultraviolet ray strong, air rarefaction, oxygen shortages, high and cold low temperature, often have in the environment that frost, wind are moistening greatly, rainwater abundant, fertile, the husky property of soil property is loosened.
The nutritive ingredient of agate card is very abundant, and protein content is higher than other root class plant, and contains the indispensable VITAMIN of the multiple mankind, mineral substance, amino acid.Its main pharmacology health-care effect is embodied in:
1, physical strength reinforcing, antifatigue.The agate card contains rich in amino acid, and rational in infrastructure, and its a high proportion of bad amino acid can improve tiring of plant protein, has the nutritional fortification effect; Contained branched-chain amino acid (leucine, Xie Ansuan, Isoleucine) plays an important role at elimination mobility central nerve fatigue and human body fatigue.Contained mineral substance zinc can be regulated the neuro-endocrinology hormone level, strengthens human body anti-fatigue ability at high temperature; 100 Ke Maka contain 77 milligrams taurine, can promote the digestion of human body to lipid, strengthen myocardial contraction.Contained vitamin B1, B2, linolic acid, linolenic acid, nutritional activities compositions such as sterol can promote each tissue of human body by blood circulation picked-up raw material, strengthen metabolism, strengthen circulation, guarantee the constant relatively of the inner physico-chemical property of body tissue.
2, endocrine regulation delays senility.The multiple alkaloid component that the agate card is contained all has effect to the male still endocrine regulation of female hormone.Contained sterol and saponin(e are as the precursor of multiple hormone, and contained meson oil glycosides and isothiocyanic acid benzyl fat also play a role to endocrine regulation, keep the elderly's endocrine system balance and stability.
3, sexual function improving improves fertility.Unique agate card alkene that the agate card contains and Ma Ka acid amides two kind of plant active substances, to improving men and women's sexual function obvious effect is arranged all, be referred to as by some developed countries " natural vigour ", contained algae resin acid, arginine can effectively improve the quality and the mobility of sperm.The precursor substance of delivery signal helps to improve the character amount in the synthetic just sexual function central nervous system of phenylalanine in amino acid contained, tyrosine and Histidine.Agate card alkene and Ma Ka acid amides enter the hypothalamus of brain with blood after by human consumption, sexual gland systems such as pituitary gland and ovary and testis, and the hormonal secretion of modulability keeps human body natural's excretory sexual hormoue and returns to normal level.
4, ease off the pressure, alleviate anxiety.Agate card extract can directly act on pituitary gland, human body is had adapt to the former state effect, and counter pressure alleviates intense strain, promotes brain power, and it is clear to keep brain, improves insomnia, eliminates tired outly, keeps good muscle power that positive effect is all arranged.
5, it is antitumor to suppress canceration. contained benzyl meson oil glycosides of agate card and the distinctive bioactive ingredients of benzyl isothiocyanic acid, it is a kind of antimitotic agent, chemocarcinogenesis (is comprised lung cancer, bladder cancer, esophagus cancer, cancer of the stomach, intestinal cancer, thyroid carcinoma, leukemia etc.), all inhibited. the contained distinctive plant sterol activeconstituents of agate card, teas phenol etc., also confirmed it is to suppress the antineoplastic active substance of canceration by medical circle. through scientist's experiment confirm, the effective constituent of edible agate card extract, have effect that strengthens macrophage phagocytic function and the effect that improves NK cell activity lipid acid, contained unsaturated fatty acids, vitamins C, health nutrient compositions such as food fibre also can play anticancer auxiliary function effectively.
6, other pharmacology health-care effect of agate card
Mineral substance such as A. high-load iron, calcium and rich in protein, amino acid have significant therapeutic effect to anaemia.
B. its abundant plant sterol and its derivative can reduce the sickness rate of coronary atherosclerotic heart disease, benign prostatauxe and amyotrophy chronic diseases significantly.Blood fat reducing effectively also.
C. its taurine that contains has anti-insane pain, hypotensive, adjusting irregular pulse, and cardiac function enhancing improves effects such as retinal function and adjusting osmotic pressure.
D. its contained steroid and adrenotrophin class material can be used for the treatment of respiratory system diseases such as asthma.
E. but agate card compound product balance human body skin pigment is eliminated the fibrosis scar tissue, recovers beautiful smooth making a breakthrough property of healthy skin effect.
F. its contained active substance and rich nutrient contents can make the human body brain alleviate anoxic, enhance metabolism, and keep resourceful, prevent alcoholism.
(3) summary of the invention
The present invention solves the agate card by fermentation, meeting loss part nutritive and health protection components more or less, and the nutritive and health protection components with the agate card remains to greatest extent, makes its health-care effect reach a kind of system wine method of optimum extent.Zhi Bei agate card cognac in this way, not only mouthfeel is good, and the fragrance aftertaste is permanent, and, long-term drinking, delaying sanility is promoted longevity.
Technical scheme of the present invention is:
A kind of agate card cognac, bright by weight agate card 5%-50%, the former wine 95%-50% of brandy, dried agate card 1%-15%, the former wine 99%-85% of brandy soaks and forms, and can follow these steps to obtain.
1, the former wine of preparation brandy.To hang down pol (110-160g/L) Fructus Vins or the fragmentation of red grape destemming, and adopt and isolate Sucus Vitis viniferae, carry out spontaneous fermentation (not adding bacterial classification) then, make Fructus Vitis viniferae wine base from stream mode.Leavening temperature should be controlled at 29-32 ℃, and when fermentation finished thoroughly1 stops, residual sugar is reduced to below the 3g/L, and volatilization acidity≤0.05% o'clock can distill, and it is standby to make the former wine of brandy.The former wine alcoholic strength of the brandy that distills out is the 39-45 degree.
2, preparation agate card.With bright agate card really clean the section or the section after dry in the shade.
3, the agate card is inserted the former steeping in wine bubble of brandy, bright agate card soak time is no less than 6 months; Dried agate card soak time is no less than 10 months.
4, the agate card cognac of making by above-mentioned preparation method, alcoholic strength can be 38 degree-44 degree.
The agate card cognac of making as stated above has following characteristics:
Color: golden yellow
Outward appearance: thorough clearly, transparent, glossy
Fragrance: strong agate card fragrance is arranged
Mouthfeel: it is mellow and full agreeable to the taste, clearly pleasant to enter the mouth.
Physics and chemistry requires: carry out the GB11856-89 standard.
(4) embodiment
Embodiments of the invention are as follows:
1, will hang down pol (110-160g/L) Fructus Vins or the fragmentation of red grape destemming, and adopt and isolate Sucus Vitis viniferae, carry out spontaneous fermentation (not adding bacterial classification) then, make Fructus Vitis viniferae wine base from stream mode.Leavening temperature should be controlled at 29-32 ℃, and when fermentation finished thoroughly1 stops, residual sugar is reduced to below the 3g/L, and volatilization acidity≤0.05% o'clock can distill, and it is standby to make the former wine of brandy.The former wine alcoholic strength of the brandy that distills out is the 39-45 degree.
2, dry in the shade after bright agate card really being cleaned section or section, insert in the former wine of brandy and soak, bright agate card soak time is no less than 6 months, and dried agate card soak time is no less than 10 months, then through coarse filtration, smart filter, can, makes agate card cognac.
Embodiment 2
Adopt the bright agate card 10% of weight, the former wine 90% of brandy; Dried agate card 3%, the former wine 97% of brandy, other condition is identical with embodiment 1.
Embodiment 3
Adopt the bright agate card 20% of weight, the former wine 80% of brandy; Dried agate card 6%, the former wine 94% of brandy, other condition is identical with embodiment 1.
Embodiment 4
Adopt the bright agate card 30% of weight, the former wine 70% of brandy; Dried agate card 9%, the former wine 91% of brandy, other condition is identical with embodiment 1.
Embodiment 5
Adopt the bright agate card 40% of weight, the former wine 60% of brandy; Dried agate card 12%, the former wine 88% of brandy, other condition is identical with embodiment 1.
Embodiment 6
Adopt the bright agate card 50% of weight, the former wine 50% of brandy; Dried agate card 15%, the former wine 85% of brandy, other condition is identical with embodiment 1.
Product of the present invention is drunk through two class people's, has all obtained unusual effect.
1: prostatitis and prostatomegaly, get up in the night to urinate every night more than three times, drink one month after, hypertrophy dwindles 2/3, no longer gets up in the night to urinate.
2: after gout was drunk one month, uric acid obviously reduced.
Soaking the agate card cognac that the agate blocking becomes with brandy, kept the beneficiating ingredient of agate card to human body to greatest extent, is new variety of wineshop family, drinks in right amount for a long time, and human body is benefited.
Claims (1)
1. an agate card cognac is characterized in that it is to soak with former wine of the brandy of following part by weight and Ma Ka to form
Bright agate card 5%--50%
The former wine 95%--50% of brandy
Dried agate card 1%--15%
The former wine 99%--85% of brandy
Wherein: the former wine of brandy prepares by the following method:
To hang down pol (110-160g/L) Fructus Vins or the fragmentation of red grape destemming, and adopt and isolate Sucus Vitis viniferae, carry out spontaneous fermentation (not adding bacterial classification) then, make Fructus Vitis viniferae wine base from stream mode.Leavening temperature should be controlled at 29-32 ℃, and when fermentation finished thoroughly1 stops, residual sugar is reduced to below the 3g/L, and volatilization acidity≤0.05% o'clock can distill, and it is standby to make the former wine of brandy.The former wine alcoholic strength of the brandy that distills out is the 39-45 degree.
Sophisticated agate card is really cleaned, be cut into sheet, according to the bright agate card of weight 5%-50%, the former wine 95%-50% of brandy, or dried agate card (bright agate card is cut into sheet to dry in the shade, insolation or mechanical drying in the sun are in order to avoid destroy agate card alkene and Ma Ka acid amides in the agate card) 1%-15% (dried agate card moisture content is no more than 10%), soak among the former wine 99%-85% of brandy.The bright agate card of soak time is no less than 6 months, and Gan Maka is no less than 10 months, so that the effective constituent in the agate card is fully extracted.Make the former wine of agate card brandy, through storage, coarse filtration, smart filter, make agate card cognac again.。
2, agate card cognac according to claim 1, its part by weight is:
Bright agate card 10%
The former wine 90% of brandy
Dried agate card 3%
The former wine 97% of brandy
3, agate card cognac according to claim 1, its part by weight is:
Bright agate card 20%
The former wine 80% of brandy
Dried agate card 6%
The former wine 94% of brandy
4, agate card cognac according to claim 1, its part by weight is:
Bright agate card 30%
The former wine 70% of brandy
Dried agate card 9%
The former wine 91% of brandy
5, agate card cognac according to claim 1, its part by weight is:
Bright agate card 40%
The former wine 60% of brandy
Dried agate card 12%
The former wine 88% of brandy
6, agate card cognac according to claim 1, its part by weight is:
Bright agate card 50%
The former wine 50% of brandy
Dried agate card 15%
The former wine 85% of brandy
7, according to each described agate card cognac of claim 1-6, its alcoholic strength can be 38 degree-44 degree.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102105505A CN101705173B (en) | 2009-11-10 | 2009-11-10 | Maca brandy and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102105505A CN101705173B (en) | 2009-11-10 | 2009-11-10 | Maca brandy and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101705173A true CN101705173A (en) | 2010-05-12 |
| CN101705173B CN101705173B (en) | 2012-08-22 |
Family
ID=42375429
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009102105505A Expired - Fee Related CN101705173B (en) | 2009-11-10 | 2009-11-10 | Maca brandy and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101705173B (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102229872A (en) * | 2010-08-11 | 2011-11-02 | 王国军 | Fermented wine suitable for women and brewing method thereof |
| CN102260620A (en) * | 2010-08-11 | 2011-11-30 | 宁成国 | Fermented wine beneficial to man health and brewing method thereof |
| CN102994346A (en) * | 2012-12-01 | 2013-03-27 | 王百鸣 | Base stock for preparing MACA wine |
| CN103589555A (en) * | 2013-10-21 | 2014-02-19 | 烟台金色庄园玛卡酒业有限公司 | Maca brandy |
| CN103710236A (en) * | 2013-11-25 | 2014-04-09 | 牛建伟 | Preparation method for maca nutritional wine |
| CN103897963A (en) * | 2014-04-08 | 2014-07-02 | 吕婉明 | Maca health care wine |
| CN104560576A (en) * | 2015-02-23 | 2015-04-29 | 酒口袋（上海）投资控股有限公司 | Lepidium meyenii walp health wine and preparation method thereof |
| CN106350399A (en) * | 2016-08-25 | 2017-01-25 | 中博绿色科技股份有限公司 | Wild kiwi fruit/maca health-preserving wine and preparation method thereof |
| CN106834012A (en) * | 2017-01-04 | 2017-06-13 | 合肥师范学院 | A kind of technological method for processing of Blueberry brandy |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1390476A (en) * | 2002-07-30 | 2003-01-15 | 杨亚军 | Health-care food and its preparing process |
| CN101537034B (en) * | 2009-04-10 | 2011-03-23 | 云南南药医药发展有限公司 | Functional health care product containing maca and preparation method thereof |
-
2009
- 2009-11-10 CN CN2009102105505A patent/CN101705173B/en not_active Expired - Fee Related
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102229872A (en) * | 2010-08-11 | 2011-11-02 | 王国军 | Fermented wine suitable for women and brewing method thereof |
| CN102260620A (en) * | 2010-08-11 | 2011-11-30 | 宁成国 | Fermented wine beneficial to man health and brewing method thereof |
| CN102260620B (en) * | 2010-08-11 | 2013-03-20 | 宁成国 | Fermented wine beneficial to man health and brewing method thereof |
| CN102229872B (en) * | 2010-08-11 | 2013-05-01 | 王国军 | Fermented wine suitable for women and brewing method thereof |
| CN102994346A (en) * | 2012-12-01 | 2013-03-27 | 王百鸣 | Base stock for preparing MACA wine |
| CN103589555A (en) * | 2013-10-21 | 2014-02-19 | 烟台金色庄园玛卡酒业有限公司 | Maca brandy |
| CN103710236A (en) * | 2013-11-25 | 2014-04-09 | 牛建伟 | Preparation method for maca nutritional wine |
| CN103897963A (en) * | 2014-04-08 | 2014-07-02 | 吕婉明 | Maca health care wine |
| CN104560576A (en) * | 2015-02-23 | 2015-04-29 | 酒口袋（上海）投资控股有限公司 | Lepidium meyenii walp health wine and preparation method thereof |
| CN104560576B (en) * | 2015-02-23 | 2016-07-20 | 酒口袋（上海）投资控股有限公司 | Maca health preserving wine and preparation method thereof |
| CN106350399A (en) * | 2016-08-25 | 2017-01-25 | 中博绿色科技股份有限公司 | Wild kiwi fruit/maca health-preserving wine and preparation method thereof |
| CN106834012A (en) * | 2017-01-04 | 2017-06-13 | 合肥师范学院 | A kind of technological method for processing of Blueberry brandy |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101705173B (en) | 2012-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101705173B (en) | Maca brandy and preparation method thereof | |
| CN101654640A (en) | Maca wine and preparation method thereof | |
| CN101245307B (en) | Melon and fruit vinegar and manufacture method thereof | |
| CN101508945A (en) | Fermented vinous liquor and preparation method thereof | |
| CN103976427B (en) | A kind of passionflower blueberry juice drink and preparation method thereof | |
| CN100519730C (en) | Process of making aromatic vinegar by using bananas | |
| CN101538516A (en) | Maca grape wine and preparation method thereof | |
| CN103013767B (en) | Method for preparing pumpkin sparkling wine | |
| CN103653117A (en) | Dendrobium nobile healthcare beverage and preparation method thereof | |
| CN101285023A (en) | Red raspberry health wine and brewing process thereof | |
| CN1710050A (en) | Low-alcohol-content nutritional yellow wine | |
| CN103194352B (en) | Rose sweet white wine beverage and preparation method thereof | |
| CN103642624A (en) | Composite fermentation type cistanche health-care wine and production technology thereof | |
| CN105062740A (en) | Rose-grape wine and preparation method thereof | |
| CN102690742B (en) | Manufacturing method of red raspberry liqueur | |
| CN103815100A (en) | Papaya tea beverage and preparation method thereof | |
| CN100396766C (en) | Tea trea flower wine and preparation method thereof | |
| CN103232911A (en) | Chinese yam and grape wine and brewing method thereof | |
| CN103602557A (en) | Cortex eucommiae-medicinal indianmulberry root-Chinese yam-mulberry-barbary wolfberry fruit compound fermented Chinese herbal medicine health-care liquor | |
| CN111269768A (en) | Flower-fragrance type beauty-maintaining and young-keeping fruit wine | |
| CN102391940A (en) | Sophora flower wine and preparation method thereof | |
| CN105062773B (en) | A kind of Composite fermentation type agate card health drink and its production technology | |
| CN103642623B (en) | A kind of Composite fermentation type purslane health-care wine and production technology thereof | |
| CN108420064A (en) | Preparation method of rose and persimmon composite enzyme | |
| CN104726288A (en) | Wolfberry and seabuckthorn ice wine production method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: LIU YOUXIAN MA YUXIANG PENG XINQUAN Effective date: 20120331 Owner name: BEIJING QILI MAKA TECHNOLOGY DEVELOPMENT CO., LTD. Free format text: FORMER OWNER: YANG YONGWU Effective date: 20120331 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100083 HAIDIAN, BEIJING TO: 100011 DONGCHENG, BEIJING |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20120331 Address after: 100011 Beijing, Dongcheng District Anwai No. 11 Building 1 501 Washington Gardens Applicant after: Beijing Qilimaka Technology Development Co., Ltd. Address before: 100083 building four, East Wang Zhuang, Beijing, Haidian District 1107 Applicant before: Yang Yongwu Co-applicant before: Liu Youxian Co-applicant before: Ma Yuxiang Co-applicant before: Peng Xinquan |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120822 Termination date: 20151110 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |